logo
Share SHARE
FONT-SIZE Plus   Neg

CytoDyn Appoints Nader Pourhassan As Interim CEO - Quick Facts

CytoDyn Inc. (CYDY: Quote) announced the appointment of Nader Pourhassan as its new interim Chief Executive Officer and Richard Trauger as its new Chief Scientific Officer.

Pourhassan brings over 20 years of advanced engineering and mathematics expertise as well as strong business acumen, to his new role. Prior to his new position as CEO, Pourhassan served as the Company's Managing Director of Business Development, and before that, as its Chief Operating Officer. He succeeds former President and CEO Kenneth Van Ness.

The appointment of Pourhassan to CEO follows the recent promotion of Richard Trauger from Managing Director of Science to Chief Scientific Officer on August 23, 2012.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
If calories are not reduced, exercise alone can have no effect on obesity, says British Sports Medicine, a peer-reviewed journal of sport and exercise medicine. The journal says the blame for expanding waist lines is directly on the type and amount of calories consumed and the poor diet generates more disease than physical inactivity, alcohol and smoking combined. Deutsche Bank (DB) on Sunday reported an about 50 percent decline in first-quarter profit, despite clocking double-digit revenue growth, as the German lender recorded hefty legal charges over allegations of rate-rigging. Casino operator Wynn Resorts said its shareholders ousted Elaine Wynn from the board, reflecting fears that her presence may lead to disharmony with the management.
comments powered by Disqus
Follow RTT